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http://dx.doi.org/10.1016/j.cell.2014.08.005Althoughmore than 100 types of RNAmodification have been described thus far,most of themwere
thought to be rare in mRNAs and in regulatory noncoding RNAs. Recent developments have un-
veiled that at least some of the modifications are considerably abundant and widely conserved.
This Minireview summarizes the molecular machineries and biological functions of methylation
(N6-methyladenosine, m6A) and uridylation (U-tail).RNAs undergo chemical modifications that can affect their activ-
ity, localization, and stability (Machnicka et al., 2013), which is
conceptually analogous to themodifications of DNA and protein.
Abundant noncoding RNAs such as rRNAs and tRNAs are exten-
sively modified, whereas mRNA modifications are thought to be
relatively low in frequency apart from the common terminal mod-
ifications, m7G cap and poly(A) tail.
Themost abundant internalmodification onmRNA is N6-meth-
yladenosine (m6A), discovered in the 1970s. Early studies esti-
mated m6A to be present at a level of approximately three to
five sites per mRNA (0.1%–0.4% of adenosines) in mammalian
cells (Bokar, 2005; Dubin and Taylor, 1975; Perry et al., 1975;
Wei et al., 1975). But the initial interest was dampened by con-
cerns that m6A may have come from contamination from rRNAs
and snRNAs and also due to the fact that mutation of specific
m6A sites did not affect mRNA abundance and processing.
Another concern was that, although viral mRNAs are frequently
modified, m6A was rarely detected in cellular mRNAs examined,
which led to the idea that adenosine methylation may occur in a
limited subset of viral and cellular mRNAs (Bokar, 2005). After
four decadesof latency, however, the interest inm6Ahasbeen re-
newed recently by developments of new sequencing techniques
and discoveries from genetic and biochemical studies.
Another ‘‘old’’ modification that recently regained attention is
tailing (30 terminal untemplated nucleotidyl addition), which
was initially noted in the 1970s (Norbury, 2013). Apart from
canonical polyadenylation, it is now clear that RNAs undergo
multiple types of tailing, including noncanonical adenylation, ur-
idylation, and guanylation (Chang et al., 2014; Norbury, 2013).
Tailing plays important roles in the small RNA pathways (Ameres
and Zamore, 2013; Ha and Kim, 2014). Accumulating evidence
suggests that mRNAs are also subject to widespread regulatory
tailing such as uridylation (Chang et al., 2014; Morozov et al.,
2010; Mullen and Marzluff, 2008; Rissland and Norbury, 2009;
Sement et al., 2013). The recent development of a high-
throughput method now offers an opportunity to examine the
30 terminal modification of mRNA at the transcriptome level
(Chang et al., 2014).980 Cell 158, August 28, 2014 ª2014 Elsevier Inc.This Minireview will focus on two emergingmodifications, m6A
and U-tail, and will summarize recent technical developments,
as well as the enzymology and biological significance of methyl-
ation and uridylation.
N6-Methyladenosine in mRNA
m6Amodification is found in rRNA, snRNA, andmRNA of viruses,
yeast, plants, and animals and is particularly prevalent in higher
eukaryotes (Bokar, 2005). The consensus sequence of m6A was
initially predicted from several m6A-containing mRNA se-
quences and was defined as ‘‘RRACH’’ ([G/A][G > A]m6AC[U >
A > C]) through in vitro assays (Harper et al., 1990). However,
the in vivo methylation state of the predicted m6A sites remained
largely unknown due to technical limitations. This changed when
two groups independently developed similar methods, MeRIP-
seq (methylated RNA immunoprecipitation followed by se-
quencing) and m6A-seq (Dominissini et al., 2012; Meyer et al.,
2012). To briefly explain the methods, RNA is fragmented into
100 nt long segments and is immunoprecipitated with anti-
m6A antibody, which results in selective enrichment of methyl-
ated RNA fragments. Eluted RNAs and input control samples
are deep sequenced, and the reads are mapped to the genome.
Using peak-calling algorithms, regions enriched in the immuno-
precipitate relative to input samples are identified as ‘‘m6A
peaks.’’ These methods allowed genome-wide mapping of
m6A modification with a resolution of 200 nt, detected over
12,000 m6A peaks in transcripts of >7,000 genes in human cells
and mouse tissues. Many of the m6A peaks are conserved be-
tween mouse and human, and they are enriched near the stop
codon. These studies also revealed that the methylation status
of some m6A sites dynamically changes in stress conditions,
implicating a potential role of m6A in stress responses. The
genome-wide m6A mapping in two yeast species (S. cerevisiae
and S. mikatae) also demonstrated a conserved and dynamically
regulated methylation during meiosis (Schwartz et al., 2013).
Other various technical approaches have been taken by
other groups to detect m6A. Methylation of a specific site can
be quantitated by a digestion-based method called SCARLET
Figure 1. The m6A Pathway and Its Cellular Functions
(A) N6-methyladenosine methylation and demethylation reactions. Methyltransferase complex containing METTL3, METTL14, and WTAP catalyzes m6A
methylation, whereas FTO and ALKBH5, the demethylases, catalyze oxidative demethylation of m6A.
(B) Domain structures of writer, eraser, and reader/effector proteins in human. METTL3, METTL14, andWTAP are components of themethyltransferase complex.
METTL3 and METTL4 have a SAM-binding domain required for m6A methylation, whereas WTAP contains no characteristic domain. Eraser proteins, FTO and
ALKBH5 demethylases, have an AlkB domain in common. Compared to ALKBH5, FTO has an additional C-terminal domain. YTHDF1,2,3 containing a YTH RNA-
binding domain are effector proteins. The P/Q/N-rich domain is known to be important for the localization of YTHDF2 to P body (Fu et al., 2014).
(C) Proposed model of the cellular function of m6A on mRNA. Reversible methylation/demethylation is thought to occur in nuclear speckles where the enzymes
are concentrated. Methylation may affect the export and splicing of mRNAs in the nucleus. Exported methylated mRNAs are recognized by YTHDF2 in the
cytoplasm and then localize to P bodies, where mRNA decay factors are enriched.(site-specific cleavage and radioactive-labeling followed by
ligation-assisted extraction and thin-layer chromatography),
although it cannot be adopted to transcriptomic analyses
because it is based on thin-layer chromatography (Liu et al.,
2013). When applied to several individual mRNAs and long
ncRNAs, SCARLET assays estimated the percentages of m6A
at specific sites to range from 6% to 80%. Additional methods
such as m6A-sensitive ligase reaction and reverse transcription
have also been proposed and need to be tested further (Dai
et al., 2007; Harcourt et al., 2013; Vilfan et al., 2013).
Additional breakthroughs came from the identification of fac-
tors involved in m6A regulation. The pathway is composed of
three classes of protein factors: ‘‘writers’’ (that methylate aden-
osine at N6 position), ‘‘erasers’’ (that demethylate m6A for
reversible regulation), and ‘‘readers’’ (the effectors that control
the modified mRNA’s fate) (Figures 1A and 1B).
The writer of m6A is a multicomponent complex composed of
METTL3 (also known asMT-A70), METTL14, andWTAP inmam-
mals (Bokar et al., 1997; Liu et al., 2014; Narayan and Rottman,
1988; Ping et al., 2014; Wang et al., 2014b). Knockdown of
METTL3 or METTL14 reduced m6A/A ratios in human cell lines
and mouse embryonic stem cells (ESCs) (Liu et al., 2014; Pinget al., 2014; Wang et al., 2014b). Each of METTL3 and METTL14
has methylation activity. But the heterodimer of the two methyl-
transferases has a strongly enhanced activity in vitro, and they
stabilize each other in vivo. METTL3 and METTL14 colocalize
in nuclear speckles together with the third component, WTAP.
WTAPwas initially known as a splicing factor, but its biochemical
role remained unknown. Knockdown of WTAP lowered the m6A
levels and decreased the amount of RNAbound toMETTL3, sug-
gesting that WTAP may recruit substrate RNAs to the enzymatic
complex (Liu et al., 2014; Ping et al., 2014). MeRIP-seq and PAR-
CLIP (photoactivatable ribonucleoside-enhanced crosslinking
and immunoprecipitation) independently performed in different
cell lines revealed that the targets of METTL3 and METTL14
largely overlap (Liu et al., 2014; Wang et al., 2014b). Moreover,
WTAP targets detected by PAR-CLIP also share the binding
motif with that of METTL3 and METTL14, which is similar to
the m6A consensus sequence (Liu et al., 2014; Ping et al.,
2014). These results indicate that the three components function
as a heterotrimeric methyltransferase in vivo (Figure 1B).
Illustrating their physiological relevance, mutations of the
METTL3 or WTAP homologs led to diverse defects in eukary-
otes. In S. cerevisiae, the MIS complex containing Ime4Cell 158, August 28, 2014 ª2014 Elsevier Inc. 981
(a METTL3 homolog), Mum2 (a WTAP homolog), and Slz1 is
responsible for mRNA methylation during meiosis, and muta-
tions in the MIS components display meiotic defect (Agarwala
et al., 2012; Clancy et al., 2002). In Arabidopsis, disruption of
MTA (a METTL3 homolog) causes early developmental arrest
and cell division defects (Zhong et al., 2008). Its depletion at a
later stage results in altered growth patterns and floral defects
(Bodi et al., 2012). Drosophila Ime4 (a METTL3 homolog) is
critical for viability and is associated with Notch signaling
during oogenesis (Hongay and Orr-Weaver, 2011). In zebrafish,
knockdown of METTL3 or WTAP led to multiple defects in early
development and increased apoptosis (Ping et al., 2014).
Furthermore, RNAi of Mettl3 or Mettl14 in mouse embryonic
stem cells downregulated pluripotencymarkers and proliferation
rates and resulted in morphological changes in ESCs (Wang
et al., 2014b). These studies collectively suggested that RNA
methylation is physiologically relevant, though it is yet to be
proven that the observed phenotypes are due to methylation of
mRNAs rather than that of other RNA classes.
Although the studies of writer made important contributions, a
critical breakthrough that revived the m6A biology actually came
from the discovery of an eraser, fat mass and obesity-associated
(FTO). The finding of FTO as an m6A demethylase implicated the
dynamic and reversible nature of m6A modification and estab-
lished a link to human health. Genome-wide association studies
found a strong correlation between a single-nucleotide polymor-
phism in the first intron of FTO and increased body mass index
and obesity risk in multiple human populations. In addition, ho-
mozygous loss-of-function mutation (Arg316Gln) is associated
with postnatal growth retardation and multiple malformations
in humans (Fawcett and Barroso, 2010). Consistent with the hu-
man data, deletion of Fto in mice resulted in altered body weight,
increased lethality, and growth retardation (Fawcett and Bar-
roso, 2010). Fto is most abundantly expressed in the brain,
particularly within hypothalamus, which is important for meta-
bolism. Another demethylase, ALKBH5, was recently discovered
(Zheng et al., 2013a). ALKBH5 has the highest expression in
testes, and the ALKBH5-deficient mice show defective sper-
matogenesis and impaired fertility, though the mice are viable
and develop to adult normally. The homologs of m6A demethy-
lases are yet to be investigated in other species. ALKBH5
appears to be conserved only in vertebrates, whereas FTO ho-
mologs have been detected in vertebrates as well as in algae
(Zheng et al., 2013b) (Figure 1B).
FTO and ALKBH5 belong to the AlkB family of the Fe(II) and
a-ketoglutarate-dependent dioxygenases. This family also in-
cludes demethylases of DNA and histones (Kurowski et al.,
2003; Zheng et al., 2013b). FTO effectively carries out oxidative
demethylation of m6A on RNA in vitro (Jia et al., 2011), and
ALKBH5 has comparable m6A demethylation activity with a pref-
erence for the m6A consensus sequence (RRACH) (Zheng et al.,
2013a). Silencing or overexpression of these factors resulted
in an increase or decrease of m6A on mRNA, respectively. FTO
forms nuclear foci that partially colocalize with nuclear speckles,
whereas ALKBH5 is tightly localized in nuclear speckles that
contain splicing factors (Jia et al., 2011; Zheng et al., 2013a).
Knockdown of ALKBH5, but not that of FTO, affects the spliceo-
some assembly. ALKBH5-depleted cells also show cytoplasmic982 Cell 158, August 28, 2014 ª2014 Elsevier Inc.accumulation of poly(A)+ RNA, suggesting that methylation may
be necessary for nuclear export of mRNA (Zheng et al., 2013a). It
remains to be determined what the molecular consequences of
FTO-mediated demethylation are and how they differ from those
of ALKBH5-mediated demethylation.
The m6A readers and their effector functions begin to be un-
covered. From a pull-down assay using a synthetic m6A RNA
bait, three YTH domain proteins (YTHDF1–3) have been identi-
fied in mammalian cells (Dominissini et al., 2012; Wang et al.,
2014a). The YTH domain family is widespread in eukaryotes
and is known to bind to ssRNA through the YTH domain, but their
functions were not known (Zhang et al., 2010). Though all
YTHDF1–3 show selective binding to m6A embedded in con-
sensus sequences, YTHDF2 has the highest affinity (Wang
et al., 2014a). YTHDF2 target sites identified by PAR-CLIP largely
overlap with m6A peaks mapped by MeRIP-seq, and they pri-
marily localize near the stop codon. YTHDF2 knockdown led to
an increase of abundance and half-lives of target mRNAs, indi-
cating that YTHDF2 is involved in RNA decay. Indeed, mRNA
half-lives were increased in accordance with the number of bind-
ing sites present in target mRNAs. Via its P/Q/N-rich N-terminal
domain, YTHDF2 localizes to processing bodies (P bodies) in the
cytoplasm where mRNA turnover factors are concentrated.
Thus, YTHDF2 may select m6A-modified mRNA through the
YTH domain and localize them to the P bodies using N-terminal
domain so as to facilitate mRNA decay (Wang et al., 2014a)
(Figures 1B and 1C).
Apart from mRNA decay (Wang et al., 2014a, 2014b), several
functions of m6A have been proposed. Initial studies proposed
splicing as the main regulatory target of m6A, based on the ob-
servations that methylation occurs in the nucleus and that
methylation sites are detected in introns of pre-mRNAs (Carroll
et al., 1990; Stoltzfus and Dane, 1982). Global discovery of
m6A sites showed that some m6A sites are indeed located in in-
tronic regions and that alternatively spliced exons and introns are
considerably more methylated than constitutively spliced ones
(Dominissini et al., 2012). A similar pattern was observed in
PAR-CLIP of METTL3 and WTAP, and depletion of METTL3 or
WTAP led to alteration in splicing isoforms (Ping et al., 2014).
In addition to splicing, other RNA processing defects have
been reported to be related to methylation. METTL3 knockdown
in mouse or human cell lines caused an apparent delay in the
nuclear exit of mature mRNA of circadian genes and showed
circadian period elongation phenotype (Fustin et al., 2013).
Conversely, depletion of ALKBH5 leads to accelerated mRNA
export (Zheng et al., 2013a) (Figure 1C). It is noteworthy
that m6A peaks are detected frequently near stop codons. This
observation implies a link to translation and/or translation-
coupled decay, though these possibilities have yet to be tested
directly.
U-Tail in mRNAs and MicroRNAs
‘‘Writers’’ of uridylation belong to a large family of ribonucleotidyl
transferases that have a catalytic domain with sequence homol-
ogy to DNA polymerase b (Norbury, 2013). These proteins were
first described as noncanonical poly(A) polymerases (PAPs),
based on the findings that ribonucleotidyl transferases such as
PAPD4 (GLD2 or TUT2) and mtPAP (TUT1) catalyze adenylation
Figure 2. Uridylation in the miRNA and mRNA Pathways
(A) Domain organization of five human terminal uridylyl transferases (writers). Red, nucleotidyl transferase domain; yellow, PAP-associated domain; dark red,
inactive nucleotidyl transferase domain; blue, C2H2-type zinc finger domain; bluish green, CCHC-type zinc finger domain.
(B) Pre-miRNA uridylation. Microprocessor composed of DROSHA and DGCR8 crops pri-miRNA to release pre-miRNA. Pre-miRNA is exported to the cytoplasm
by EXPORTIN5 (EXP5). In embryonic stem cells and in certain cancer cells in which LIN28 or Lin28B is expressed, pre-let-7 is oligo-uridylated by TUT4 or TUT7
and the U-tail blocks Dicer processing and recruits exonuclease DIS3L2. However, in differentiated cells in which LIN28 is absent, precursors of most let-7
members are mono-uridylated by TUT2, TUT4, or TUT7, which facilitates DICER processing.
(C) Model for mRNA degradation. Most mRNAs undergo deadenylation at the beginning of decay. Poly(A) tail is removed by deadenylases (shown here as Ccr4-
Caf1 complex as an example). Following deadenylation, mRNAs are degraded bidirectionally by Xrn1 following decapping by Dcp1-Dcp2 (50-to-30 decay
pathway) and by exosome (30-to-50 decay pathway). Uridylation is thought to act redundantly with deadenylation in S. pombe to stimulate decapping. TUTase
uridylates poly(A)+ mRNAs (Cid1 in S. pombe, CutA in A. nidulans, or URT1 in A. thaliana). Lsm1-7 binds to the U-tail and enhances decapping, which triggers 50-
to-30 decay by Xrn1.
(D) Degradation pathway for replication-dependent histone mRNAs. Degradation is initiated by oligo-uridylation. Then LSm1-7 binds to the U-tail and stimulates
decapping and 50-to-30 decay by XRN1. Some histone mRNAs are also degraded in the 30-to-50 direction by 30hExo and PM/Scl-100 (one of exosome
components).of cytoplasmic mRNA and mitochondrial mRNA, respectively
(Tomecki et al., 2004; Wang et al., 2002). Some ribonucleotidyl
transferases have uridylation activity; hence, noncanonical
PAPs are also called terminal uridylyl transferases (TUTs) or
poly(U) polymerases (PUPs) (Norbury, 2013). Humans have
seven proteins with potential TUT activity. Figure 2A shows five
human TUTs that have been proposed to uridylatemRNAs ormi-
croRNAs. Although the catalytic domains show sequence ho-
mology among TUTs, their overall domain structures have little
similarity between species, making it difficult to predict ortholo-
gous relationships. Budding yeast S. cerevisiae is the only eu-
karyotic model organism that lacks an apparent TUT homolog,
whereas fission yeast S. pombe possesses at least one TUT.
The first glimpse of uridylation in cytoplasmic RNA came from
the description of nontemplated U residues on the 50 cleavage
products from miRNA-mediated slicing (Shen and Goodman,
2004). Soon after, miRNA uridylation was found in Arabidopsis
HEN1 mutant that is defective in 20-O-methyl modification atthe terminal ribose (Li et al., 2005). Uridylation plays regulatory
roles in the miRNA pathway, with the precursor of let-7 (pre-
let-7) being the most extensively studied example (Heo et al.,
2008; Newman et al., 2011) (Figure 2B). In differentiated cells,
precursors of most let-7 members are mono-uridylated by
ZCCHC11 (TUT4), ZCCHC6 (TUT7), or PAPD4 (GLD2 or TUT2)
(Heo et al., 2012). Mono-U tail extends the 30 overhang of pre-
let-7 and thereby facilitates Dicer processing and miRNA
maturation. But in ESCs and in certain cancer cells in which an
oncofetal protein LIN28 or LIN28B is expressed, pre-let-7 is
oligo-uridylated, and the long U-tail blocks Dicer processing
and inhibits miRNA maturation (Hagan et al., 2009; Heo et al.,
2008, 2009). Thus, there is a functional duality in uridylation de-
pending on the length of the U-tail. What LIN28 does is to stabi-
lize the interaction between the substrate and TUTs, thereby
enhancing processivity of reaction (Yeom et al., 2011). In animals
and plants, there have been many reports of uridylation and ad-
enylation of mature miRNAs, which affect stability and activity ofCell 158, August 28, 2014 ª2014 Elsevier Inc. 983
miRNAs. Tailing in the small RNA pathway has been reviewed
elsewhere in detail (Ameres and Zamore, 2013; Ha and Kim,
2014).
Mounting evidence indicates that mRNAs are generally sub-
ject to uridylation, which challenges the way that we think about
mRNA tails (Figure 2C). Short uridine tails (typically mono- or di-)
were initially found on mRNAs of fission yeast S. pombe (Riss-
land et al., 2007; Rissland and Norbury, 2009). Deletion of the
TUTase gene cid1 resulted in an increase of mRNA stability,
though it was tested for a single gene (urg1). Uridylated tran-
scripts accumulated when deadenylation factor (Ccr4) or de-
capping factors (Dcp1 and Lsm1) were mutated. A related
phenomenon was observed in filamentous fungusAspergillus ni-
dulans, where mRNAs frequently contain an extended tail with
mixed C and U residues with the consensus CUCU (Morozov
et al., 2010, 2012). When ribonucleotidyl transferase CutA (or
CutB) gene was deleted, mRNA decay rate was decreased.
These results implicate that uridylation and deadenylation
may act redundantly to stimulate decapping and decay of
mRNA. Thus, despite differences in sequences, functions of
downstream effectors may be conserved among fungi species.
Uridylation has also been found on poly(A)+ mRNAs of higher eu-
karyotes, but it remains to be determined whether or not the
function of uridylation is conserved. In Arabidopsis, short U-tails
occur preferentially on deadenylated mRNAs, suggesting a link
to mRNA decay (Sement et al., 2013). However, in the mutant
of urt1, which is responsible for uridylation, 30 trimmed decay in-
termediates accumulated without significant changes in mRNA
half-lives. Accordingly, it was proposed that uridylation may sim-
ply block 30 trimming to establish the 50-to-30 directionality of
degradation rather than to enhance the rate of decay.
Some poly(A) RNAs are also known to be uridylated. The
replication-dependent histone mRNAs have a conserved stem-
loop structure instead of a poly(A) tail at their 30 end, and they
are rapidly degraded at the end of S phase or when DNA replica-
tion is inhibited during S phase (Mullen and Marzluff, 2008). The
30 ends of histone mRNAs are oligo-uridylated during their
degradation (Figure 2D). Recent studies analyzed degradation
intermediates of histone mRNA using a circular RT-PCR assay
or a high-throughput sequencing approach, revealing that uridy-
lation facilitates decay in both directions (Hoefig et al., 2013;
Mullen andMarzluff, 2008; Slevin et al., 2014). The 50-30 degrada-
tion is carried out by XRN1 following decapping. The 30-50 degra-
dation is mediated initially by 30hExo (also known as Eri1) and
subsequently by PM/Scl-100 (a component of exosome; also
known as RRP6). When oligo-uridylation is inhibited, the rate
of degradation decreased (Mullen and Marzluff, 2008; Schmidt
et al., 2011; Su et al., 2013). As for uridylating enzymes for
the histone mRNA, an initial study proposed mtPAP (TUT1)
and PAPD5 (TUT3) (Mullen and Marzluff, 2008), whereas two
following reports instead implicated ZCCHC11 (TUT4) (Schmidt
et al., 2011; Su et al., 2013). Other poly(A) mRNAs such as
endonucleolytic cleavage products also seem to be subject to
tailing and decay. An example is miRNA-directed 50 cleavage
products that are oligo-uridylated in plants andmammalian cells,
though the TUTs for this reaction are yet to be identified (Shen
and Goodman, 2004). Notably, however, a related phenomenon
has been studied in green algae Chlamydomonas (Ibrahim et al.,984 Cell 158, August 28, 2014 ª2014 Elsevier Inc.2006). An adenylyl transferase MUT68 mediates oligo-adenyla-
tion of the siRNA-mediated cleavage product and induces decay
of adenylated RNA.
Further studies are needed to understand the commonalities
and variations among these seemingly related phenomena
from diverse species. Also, because the above studies were per-
formed on a few individual genes from each species, it is impor-
tant to examine howwidespread uridylation is and how generally
it contributes to gene regulation.
Recently, global investigation of mRNA tail wasmade possible
by the development of a high-throughput technique called
TAIL-seq (Chang et al., 2014). Briefly, RNAs are ligated to a bio-
tinylated 30 adaptor. Following fragmentation, the 30-most frag-
ments are purified with streptavidin beads and ligated to the 50
adaptor. Paired-end sequencing of the cDNA is used to identify
the transcript (51 nt from the 50 end) and determine the 30 tail se-
quences (231 nt from the 30 end). Due to the difficulties associ-
ated with sequencing homopolymeric poly(A) tail, fluorescence
signals are used for a machine learning algorithm, which allows
the accurate determination of poly(A) tail length. TAIL-seq re-
vealed that a surprisingly large proportion of poly(A)+ mRNAs
are uridylated in mammalian cells (Chang et al., 2014). More
than 85% of mRNA species are uridylated at a frequency of
higher than 1%. Most U-tails are short (1–4 uridines) at the
steady state. Similarly to plants, U-tails are found mostly on
mRNAs with shortened A tails (<25 nt). Moreover, uridylation
frequency correlates negatively with mRNA half-life at the global
level. Thus, uridylation may be involved in mRNA decay in most
eukaryotes (with some exceptions, such as S. cerevisiae).
Because the current model for mRNA decay is largely based
on studies of S. cerevisiae that lacks the uridylation machinery,
future studies may introduce substantial changes to our under-
standing of general mRNA decay. It will be important to identify
the writer (TUT) for mammalian poly(A)+ mRNA and to under-
stand how the uridylyl transferase recognizes nonfunctional
mRNAs selectively. It is also necessary to reveal what the direct
molecular consequences of uridylation are and if and how
uridylation is regulated during developmental and pathological
transitions.
It is currently unclear whether uridylation of mRNA and miRNA
is a reversible process—that is, whether deuridylase plays a reg-
ulatory role as an ‘‘eraser.’’ A 30-50 exonuclease DIS3L2 has
recently been shown to act preferentially on oligo-U-tails of
mRNAs (in fission yeast) and on precursor of let-7 (in mice and
humans) (Chang et al., 2013; Malecki et al., 2013; Ustianenko
et al., 2013). The structure of mouse Dis3l2 in complex with an
oligo-U (U14) has recently been reported, which showed exten-
sive uracil base-specific interaction (Faehnle et al., 2014). How-
ever, as DIS3L2 degrades the whole RNA body, it would bemore
appropriate to consider this enzyme as a putative ‘‘reader/
effector.’’ It is expected that there are additional effectors that
selectively recognize U-tails. For example, the Lsm1-7 complex
is known to bind to oligo-U-tracts and enhance decapping
in vitro (Song and Kiledjian, 2007). In yeast, Lsm1-7 complex
contributes to the decay of uridylated poly(A)+ mRNAs (Rissland
and Norbury, 2009), and in mammals, the Lsm1-7 complex par-
ticipates in the decay of uridylated histone mRNAs through its
interaction with SLBP (stem-loop binding protein) and 30hExo
(Hoefig et al., 2013; Lyons et al., 2014; Mullen and Marzluff,
2008). Thus, the Lsm1-7 complex may be another conserved
reader/effector that selectively recognizes U-tails. It is currently
unclear what the molecular basis of U-tail recognition is and
how many downstream effectors exist.
Perspectives
Pioneering studies on the methylome and 30-terminome of RNA
have revealed interesting new layers of gene expression. How-
ever, there is yet no consensus as to the exact function of m6A
and U-tail, and many questions are pending without clear an-
swers. Are there additional writers, erasers, and readers for
m6A? What are the writers (TUTs) and readers for U-tails of
mammalian mRNAs? How do these factors achieve specificity?
Is uridylation reversible? How are they regulated and connected
to cell-signaling pathways? Which human diseases are associ-
ated with such modifications?
Finding the factors involved in the pathway will provide crucial
information on the mechanism and function of methylation and
uridylation. It is expected that many factors will emerge from
affinity purification/immunoprecipitation followed by proteomic
analyses. Candidate approaches based on homology to known
factors will also be fruitful when combined with RNAi. The
following step will be to investigate the factors in detail to gain
mechanistic understanding. Structural and biochemical studies
of METTL3-METTL14-WTAP and YTHDF2 are much needed
to understand how the substrates are selected. Structures of
TUT and the higher eukaryotic Lsm1-7 in complex with RNA
are also necessary to reveal how U-tail is generated and recog-
nized. Furthermore, genetic studies will teach us what develop-
mental roles themodification factors play, though a caveat is that
it would be difficult to segregate their effects on different RNA
classes. Genome editing tools are likely to accelerate the func-
tional studies of the modification factors.
There are intriguing commonalities between m6A modification
and U-tailing. Both modifications are conserved widely in eu-
karyotes. Bothm6A andU-tail serve asmolecular marks that pro-
vide binding sites for their effectors. m6A is selectively bound to
the YTH domain proteins, whereas U-tail is recognized by
DIS3L2 or the Lsm1-7 complex. Intriguingly, the most plausible
function of m6A and U-tail is to facilitate mRNA decay. It will be
interesting to ask whether there is any interplay between these
two modifications.
The rapid progress in the biology of m6A and tailing was
possible, in part, due to the development of new technologies
that allowed genome-wide detection of the modifications.
Although these methods will continue to serve as potent tools,
further technical improvement is necessary. For instance,
MeRIP-seq and m6A-seq suffer from a low resolution, so it is
currently impossible to identify the modification sites at a sin-
gle-nucleotide resolution. In addition, MeRIP-seq and m6A-seq
can only detect the relative abundance of modification and
cannot quantitate the absolute stoichiometry of m6A on each
site. Additional approachesmay become available by combining
crosslinking or chemical modification to increase resolution. As
for the detection of U-tails, the current method, TAIL-seq, suc-
cessfully offers genome-wide and quantitative profiles of tail se-
quences. However, it needs further improvement to effectivelyremove abundant ncRNA contaminants so as to increase
sequencing depth and lower the cost. TAIL-seq is expected to
be used not only to investigate uridylation, but also to study other
features of 30 terminome, such as deadenylation, endonucleo-
lytic cleavage, and guanylation.
In this Minireview, we only dealt with m6A and U-tail, but some
of the main messages from this area of research are that RNA is
not different from DNA or protein in its capacity to be regulated
by postsynthetic modifications and that there may be additional
underestimatedmodifications that contribute to gene regulation.
Other types of such ‘‘epitranscriptomic’’ modifications may
deserve attention in the future, and the potential candidates
include pseudouridylation, 5-methyl cytosine, and 20-O-methyl-
ation. Effective tools that detect such modifications may open
new windows in RNA biology and beyond.
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